Adenoviral-Mediated p53 Gene Transfer to Non-small Cell Lung Cancer Through Endobronchial Injection
Authors:
- Michael MackMMMichael Mack
- Jack RothJRJack Roth
- Stephen SwisherSSStephen Swisher
- Scott ProkschSPScott Proksch
- James MerrittJMJames Merritt
- John NemunaitisJNJohn Nemunaitis
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Deletion of the Adenoviral E1b-19kD Gene Enhances Tumor Cell Killing of a Replicating Adenoviral VectorHuman Gene Therapy, 2000
- Parenteral Gene Therapy with p53 Inhibits Human Breast Tumors In Vivo Through a Bystander Mechanism Without Evidence of ToxicityHuman Gene Therapy, 1997
- Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer.Nature Medicine, 1996
- Safety Evaluation of Ad5CMY- p53 In Vitro and In VivoHuman Gene Therapy, 1995
- Intermediate dose rate remote afterloading brachytherapy for intraluminal control of bronchogenic carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1990
- Nd:YAG Laser BronchoscopyChest, 1988
- An evaluation of the palliative role of radiotherapy in inoperable carcinoma of the bronchusClinical Radiology, 1988
- The response of atelectasis from lung cancer to radiation therapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1986
- Laser therapy in 100 tracheobronchial tumours.Thorax, 1985
- Palliative radiotherapy for inoperable carcinoma of the lung: Final report of a rtog multi-institutional trialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1985